Abstract
Heart failure carries significant morbidity and mortality burden, with median survival from onset of symptoms been reported as low as 1.7 years among men and 3.2 years among women. It is the only major cardiovascular disease which is increasing in incidence and prevalence. There are several reasons for this including general aging of the population, improved outcomes from acute cardiovascular disease, and worsening risk factor profile in United States including increasing obesity and diabetes trends. Heart failure is also widely prevalent, with a reported prevalence of about 5 million people in the United States. A wide variety of demographic characteristics, life style factors, comorbidites, pharmacologic exposures, biochemical markers, echocardiographic parameters, and genetic markers have been linked to heart failure risk. Several risk factors such as increasing age, male gender, and prior MI are well established with respect to new onset heart failure chances whereas others risk factors such as many of the genetic markers are more recently discovered and need to undergo further evaluation to assess their association. This review article outlines the current state of the literature on risk factors for developing heart failure.
Keywords: Heart failure, risk factors, hypertension, myocardial infarction, diabetes
Current Cardiology Reviews
Title: Risk Factors for Development of Heart Failure
Volume: 3 Issue: 1
Author(s): Jennifer Listerman, Robert L. Huang, Carrie Geisberg and Javed Butler
Affiliation:
Keywords: Heart failure, risk factors, hypertension, myocardial infarction, diabetes
Abstract: Heart failure carries significant morbidity and mortality burden, with median survival from onset of symptoms been reported as low as 1.7 years among men and 3.2 years among women. It is the only major cardiovascular disease which is increasing in incidence and prevalence. There are several reasons for this including general aging of the population, improved outcomes from acute cardiovascular disease, and worsening risk factor profile in United States including increasing obesity and diabetes trends. Heart failure is also widely prevalent, with a reported prevalence of about 5 million people in the United States. A wide variety of demographic characteristics, life style factors, comorbidites, pharmacologic exposures, biochemical markers, echocardiographic parameters, and genetic markers have been linked to heart failure risk. Several risk factors such as increasing age, male gender, and prior MI are well established with respect to new onset heart failure chances whereas others risk factors such as many of the genetic markers are more recently discovered and need to undergo further evaluation to assess their association. This review article outlines the current state of the literature on risk factors for developing heart failure.
Export Options
About this article
Cite this article as:
Listerman Jennifer, Huang L. Robert, Geisberg Carrie and Butler Javed, Risk Factors for Development of Heart Failure, Current Cardiology Reviews 2007; 3 (1) . https://dx.doi.org/10.2174/157340307779939916
DOI https://dx.doi.org/10.2174/157340307779939916 |
Print ISSN 1573-403X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6557 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Multitasking of Neuropeptide Y through the Lens of Motifs
Recent Patents on CNS Drug Discovery (Discontinued) Gene Therapy for Familial Hypercholesterolemia
Current Pharmaceutical Design The Anticancer Properties of Dietary Polyphenols and its Relation with Apoptosis
Current Pharmaceutical Design Transforming Non-Selective Angiotensin-Converting Enzyme Inhibitors in C- and N-domain Selective Inhibitors by Using Computational Tools
Mini-Reviews in Medicinal Chemistry Meet Our Editorial Board Member
Current Cardiology Reviews Glucagon and Glucagon-Like Peptide Receptors as Drug Targets
Current Pharmaceutical Design Therapeutic Apheresis in Metabolic Syndrome
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Preservation Solutions for Solid Organ Transplantation
Mini-Reviews in Medicinal Chemistry Nitric Oxide and Protection against Cardiac Ischemia
Current Pharmaceutical Design Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review
Current Medicinal Chemistry Cell Adhesion Molecules and Cadmium
Current Chemical Biology Platelet Resistance to the Anti-Aggregating Agents in the Insulin Resistant States
Current Diabetes Reviews Peroxisome Proliferator-Activated Receptors: Role of Isoform Gamma in the Antineoplastic Effect of Iodine in Mammary Cancer
Current Cancer Drug Targets Treatment with Cinacalcet in Hemodialysis Patients with Severe Secondary Hyperparathyroidism, Influences Bone Mineral Metabolism and Anemia Parameters
Current Drug Therapy Diuretic-Associated Electrolyte Disorders in the Elderly: Risk Factors, Impact, Management and Prevention
Current Drug Safety Development and Engineering of Lymphatic Endothelial Cells: Clinical Implications
Current Pharmaceutical Design Low Molecular Weight and Oligomeric Chitosans and Their Bioactivities
Current Topics in Medicinal Chemistry Adiponectin and Cardiovascular Disease: Mechanisms and New Therapeutic Approaches
Current Medicinal Chemistry Fetal Risks of Maternal Diabetes
Current Women`s Health Reviews Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets